GET DAILY SIGNALSNational Healthcare Properties (NHP): What to Watch in the Upcoming Q3 Earnings Report
Key Takeaways
- National Healthcare Properties (NHP) is scheduled to report results for the quarter ended September 30, 2026, after the market close on Wednesday, November 4, 2026, with a conference call the following morning.
- As a real estate investment trust (REIT), NHP's performance is best measured through funds from operations (FFO) and net operating income (NOI) rather than traditional earnings per share.
- The company is mid-transition toward becoming a pure-play senior housing operator (its "SHOP" segment) while divesting its outpatient medical facilities (OMFs).
- In the second quarter of 2026, same-store cash NOI in the senior housing segment rose 20.1% year over year, prompting management to raise its full-year SHOP NOI growth outlook.
- Investors will be watching for updates on the roughly $531 million OMF sale, a $244 million senior housing acquisition pipeline, and progress on balance-sheet deleveraging.
Earnings Context and Why It Matters
National Healthcare Properties, Inc. is a self-managed healthcare REIT that listed on Nasdaq in April 2026. It is carrying out a clear strategy of selling lower-growth outpatient medical facilities and directing proceeds into senior housing. This upcoming report matters because it provides the first complete look at whether the shift is producing steadier, higher-quality cash flows. Senior housing remains a key area of interest for investors, supported by an aging U.S. population and improving occupancy, yet the sector continues to deal with labor costs and operating expenses. For a company still early in its public life, the third-quarter update serves as an important check on execution, guidance reliability, and progress toward a more focused portfolio. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Earnings Expectations
Because NHP is a REIT, attention centers on FFO and NOI rather than GAAP earnings per share, which can be affected by depreciation and one-time items. Wall Street’s overall view remains constructive heading into the report, with an average “Buy” rating and a 12-month price target near $19, though individual targets range from roughly $17 to $21. Recent focus has been on the senior housing operating segment. In the second quarter of 2026, same-store cash NOI there increased 20.1% year over year, leading management to raise full-year SHOP NOI growth guidance and announce $400 million of senior housing acquisitions completed or under agreement. For the third quarter, investors will likely compare same-store NOI growth, occupancy, and per-unit revenue trends against that prior momentum while tracking progress on the announced divestitures.
Market Reaction and Investor Sentiment
Sentiment ahead of the release is cautiously optimistic yet centered on execution. Analysts have generally kept constructive ratings during the portfolio transition, although some price-target adjustments in recent weeks reflect differing views on the pace of value creation. With limited post-IPO trading history, the stock’s response will probably depend less on headline numbers and more on qualitative signals such as the path of same-store senior housing NOI, clarity on divestiture timing, and any updates to full-year guidance. Key risks include delays in OMF sale closings, weaker senior housing occupancy or pricing, and higher financing costs that could affect acquisition returns.
Forward Outlook and Key Factors to Monitor
The most important item to watch after this report is whether NHP confirms or adjusts its raised full-year SHOP NOI growth guidance. Sustained same-store NOI growth above 20% would support the investment case, while any slowdown might prompt questions about the durability of the senior housing recovery.
Portfolio transformation will stay central. Investors should track the timing and pricing of the roughly $531 million outpatient medical facility sale as well as progress on the $244 million senior housing acquisition pipeline. The company has indicated these transactions should complete the move to a pure-play senior housing portfolio and help lower leverage relative to adjusted EBITDA.
Finally, the broader operating environment warrants attention. Labor costs, occupancy trends, rental-rate growth in senior housing, and the interest-rate backdrop that influences borrowing costs and REIT valuations will shape how the market views NHP’s results in coming quarters.
Exploring AI Tools for Portfolio Insights
In my own research process, I find Tickeron’s AI Screener helpful for quickly filtering healthcare REITs and other sectors around earnings season. It allows users to apply customizable criteria such as industry focus, technical indicators, and performance metrics to surface ideas more efficiently than manual reviews. This kind of tool can serve as a practical starting point when evaluating companies like NHP during transition periods.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
NHP in upward trend: price may ascend as a result of having broken its lower Bollinger Band on October 14, 2026
NHP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 12 of 16 cases where NHP's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 75%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where NHP's RSI Indicator exited the oversold zone, 8 of 14 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 57%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 17 of 35 cases where NHP's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 49%.
The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on NHP as a result. In 23 of 43 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 53%.
The Moving Average Convergence Divergence (MACD) for NHP just turned positive on October 30, 2026. Looking at past instances where NHP's MACD turned positive, the stock continued to rise in 20 of 27 cases over the following month. The odds of a continued upward trend are 74%.
Following a +2.72% 3-day Advance, the price is estimated to grow further. Considering data from situations where NHP advanced for three days, in 22 of 33 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
Bearish Trend Analysis
NHP moved below its 50-day moving average on September 30, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NHP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 52%.
The Aroon Indicator for NHP entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 45 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.071) is normal, around the industry mean (3.130). P/E Ratio (-8.464) is within average values for comparable stocks, (29.108). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.649). Dividend Yield (0.019) settles around the average of (0.049) among similar stocks. P/S Ratio (1.721) is also within normal values, averaging (6.013).
The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating fairly steady price growth. NHP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NHP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 58, placing this stock worse than average.
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry PublishingBooksMagazines
Advertisement